当前位置: X-MOL首页全球导师 海外导师 › Drake, Marcus

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Fry, C, Gammie, A, Drake, M, Abrams, P, Kitney, D & Vahabi, B, 2016, ‘Estimation of bladder contractility from intravesical pressure-volume measurements’. Neurourology & Urodynamics. Osman, NI, Marzi, VL, Cornu, JN & Drake, MJ, 2016, ‘Evaluation and Classification of Stress Urinary Incontinence: Current Concepts and Future Directions’. European Urology Focus, vol 2., pp. 238-244 Macdiarmid, S, Al-Shukri, S, Barkin, J, Fianu-Jonasson, A, Grise, P, Herschorn, S, Saleem, T, Huang, M, Siddiqui, E, Stölzel, M, Hemsted, C, Nazir, J, Hakimi, Z, Drake, MJ & , 2016, ‘Mirabegron as Add-on Treatment to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE study’. Journal of Urology, vol 196., pp. 809-818 Cocci, A, Gacci, M, Drake, M, Castellini, G, Ricca, V, Forti, G, Wu, F & Maggi, M, 2016, ‘P-06-005 Lower urinary tract symptoms, depression and adverse life events: data from the European Male Ageing Study: 18th Congress of the European Society for Sexual Medicine’. The Journal of Sexual Medicine, vol 13., pp. S228-S229 Drake, M, 2016, ‘Re: α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies’. European Urology, vol 70., pp. 397 Drake, M, 2016, ‘Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?’. European Urology., pp. 134-135 Drake, M, Lewis, AL & Lane, A, 2016, ‘Urodynamic Testing for Men with Voiding Symptoms Considering Interventional Therapy: The Merits of a Properly Constructed Randomised Trial’. European Urology, vol 69., pp. 759-760 Drake, M, Chapple, C, Esen, A, Athanasiou, S, Cambronero, J, Mitcheson, D, Herschorn, S, Saleem, T, Huang, M, Siddiqi, E, Stölzel, M, Herholdt, C & MacDiarmid, S, 2016, ‘Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised, Double-blind, Multicentre, Phase 3b Study (BESIDE)’. European Urology, vol 70., pp. 136-145 Drake, MJ, 2016, ‘The current hot topics in functional urology’. BJU International, vol 117., pp. 711 Drake, M, 2016, ‘Overactive Bladder’. in: Alan Wein (eds) Campbell Walsh Urology.

推荐链接
down
wechat
bug